» Articles » PMID: 39999521

Breast Arterial Calcification As a Cardiovascular Risk Factor: Time to "Bust" It Out

Overview
Journal JACC Adv
Date 2025 Feb 25
PMID 39999521
Authors
Affiliations
Soon will be listed here.
References
1.
Zelniker T, Wiviott S, Raz I, Im K, Goodrich E, Bonaca M . SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet. 2018; 393(10166):31-39. DOI: 10.1016/S0140-6736(18)32590-X. View

2.
Ledwidge M, Gallagher J, Conlon C, Tallon E, OConnell E, Dawkins I . Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA. 2013; 310(1):66-74. DOI: 10.1001/jama.2013.7588. View

3.
Margolies L, Yip R, Hwang E, Oudsema R, Subramaniam V, Hecht H . Breast Arterial Calcification in the Mammogram Report: The Patient Perspective. AJR Am J Roentgenol. 2018; 212(1):209-214. DOI: 10.2214/AJR.18.20171. View

4.
Wright A, Carr M, Kontopantelis E, Leelarathna L, Thabit H, Emsley R . Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes. Diabetes Care. 2022; 45(4):909-918. DOI: 10.2337/dc21-1113. View

5.
Koh T, Tan H, Ravi P, Sng J, Yeo T, Tan B . Association Between Breast Arterial Calcifications and Cardiovascular Disease: A Systematic Review and Meta-analysis. Can J Cardiol. 2023; 39(12):1941-1950. DOI: 10.1016/j.cjca.2023.07.024. View